Quickly verify claims by accessing the underlying experimental data and figures.
Press Enter β΅ to solve
Fuel Your Discoveries
"The most exciting phrase to hear in science, the one that heralds new discoveries, is not 'Eureka!' but 'That's funny...'"
- Isaac Asimov
Quick Explanation
Copied
What this paper claims (and what it actually tests)
The study reports that co-culturing tamoxifen-resistant MCF-7/T with estrogen-dependent MCF-7 drives an irreversible gain of tamoxifen resistance in recipient MCF-7 cells, and that this correlates with an EMT-like proteome program featuring increased SNAIL1/p-NF-ΞΊB, decreased ERΞ± transcriptional activity, and elevated EMT marker N-cadherin.
Long Explanation
Paper Review (skeptical, evidence-based): Horizontal Transfer of Tamoxifen Resistance in MCF-7 Cell Derivates: Proteome Study
Key biology
Horizontal/neighbor-dependent acquisition of tamoxifen resistance in an ER-dependent breast cancer model, linked to SNAIL1/NF-ΞΊB activation and ERΞ± transcriptional downshift.
Figure 1 β Experimental design logic (what is transferred?)
Recipient acquisition test: Mix MCF-7 (estrogen-dependent) with GFP-labeled resistant MCF-7/T clones for 1β4 weeks; then apply tamoxifen for 3 days and quantify each populationβs viability/growth.
Disconnection control: Repeat co-culture using 0.4 Β΅m transwell inserts; the authors report prevention of resistance transfer.
Stability test: Recipient cells are cloned after co-culture and show partial resistance retained over at least ~80 days of autonomous growth.
Figure 2 β Proteomics scale + overlap
The authors report ~1.8k confidently identified proteins per condition and then compare differentially expressed proteins (DEPs) between resistant and control clones.
Figure 3 β Differential proteome overlap in the two resistant lines
The authors state they found 21 common differentially expressed proteins (20 upregulated, 1 downregulated) across both resistant lines under their DEP comparison criteria.
Figure 4 β Example resistance-associated proteins reported as common DEPs
The paper highlights 6 common proteins described as associated with drug/hormonal resistance: ISOC1, PFKP, PIP, PSAP, S100A14, and keratins (KRT19 and related keratins are also listed in the table excerpt as common DEPs).
Critical note: The table excerpt in the prompt appears to show fold-change numbers per comparison; the plot uses those explicit numeric entries. The paperβs full text may define directionality (e.g., whether values are βMCF-7/T relative to MCF-7β or vice versa) that is not fully recoverable from the excerpt alone.
Figure 5 β Mechanistic readouts used to connect proteomics to EMT/NF-ΞΊB/SNAIL1/ERΞ±
The authors measure: (i) SNAIL1/SLUG and (ii) NF-ΞΊB p65 and phospho-p65 by Western blot; (iii) N-cadherin by immunohistochemistry; (iv) ERΞ± content and ERΞ± transcriptional activity using an ERE-luciferase reporter.
Epistemic caution: This visualization encodes qualitative statements (βincreased/unchanged/decreasedβ) from the paper; the prompt does not include numeric densitometry values.
Skeptical critique β key strengths and red flags
Strengths (what the paper does well)
Design includes a physical disconnection control (transwell 0.4 Β΅m) aimed at distinguishing contact-dependent vs purely diffusible/paracrine mechanisms.
Resistance is tested for stability via cloning and an extended period of autonomous growth, rather than relying only on short-term co-culture effects.
Multi-layer mechanistic alignment: proteomics + Western blot + immunohistochemistry + ERΞ± reporter activity are brought together under an EMT/NF-ΞΊB/SNAIL1/ERΞ± axis.
Red flags / limitations (what could mislead)
βHorizontal transferβ is operationally inferred from phenotype acquisition under co-culture and loss when physically separated, but the study does not (in the provided text) directly demonstrate the causal molecular carrier (exosomes vs microvesicles vs transfer via direct contacts) or rule out selection effects.
Proteomics is association-heavy: identifying common DEPs does not establish causality for tamoxifen resistance; several proteins highlighted are plausible but not functionally validated in the excerpt.
Reporter and protein level separation is a strength mechanistically, but it also raises a key question: what changes in ERΞ± transcriptional machinery downstream of receptor binding? The study reports ERΞ± protein level not significantly changed while transcriptional activity decreases.
Statistical detail may be insufficient for DEP robustness: the methods mention a βtwo-dimensional two-sample testβ with p<0.05 and fold-change thresholds, but the excerpt does not expose multiple-testing correction (e.g., FDR across proteins) for DEPs; without it, false positives may rise.
Directly testable falsification points (from their stated claims)
Phenotype transfer claim: Demonstrate that co-culturing MCF-7 with MCF-7/T does not increase tamoxifen resistance in recipient MCF-7 cells under the same conditions and cloning strategy.
Contact-dependence claim: Show that transwell disconnection does not prevent transfer (or that transfer still occurs when direct contacts are prevented), which would weaken their mechanistic conclusion.
EMT/NF-ΞΊB/SNAIL1 causality: Perturb SNAIL1 or NF-ΞΊB activation in recipient acquisition experiments and test whether resistance transfer is attenuated.
Paper-level mechanistic hypothesis (most supported by the provided evidence)
The most defensible mechanistic statement from this paper is: co-culture with tamoxifen-resistant MCF-7/T cells induces an EMT-like state in recipient MCF-7 cells (SNAIL1β, phospho-NF-ΞΊBβ, N-cadherin partial gain, ERΞ± transcriptional activityβ), and this state correlates with stable functional tamoxifen resistance.
Confidence: moderate for correlation; causal carrier identity and whether specific proteins are sufficient/necessary remain unresolved in the provided excerpt.
Author reviews (BGPT links)
If your BGPT database uses the full author names differently, these links still route to author-review searches for the closest exact strings.
Feedback:
Updated: March 23, 2026
BGPT Paper Review
Study Novelty
70%
The novelty is methodological-mechanistic rather than entirely new: it frames tamoxifen resistance as transferable under contact conditions and links the phenotype to an EMT/NF-ΞΊB/SNAIL1/ERΞ± transcriptional readout plus shared proteomic changes. While horizontal transfer concepts exist in resistance biology, the specific co-culture-to-proteome linkage in this model is a moderately novel presentation.
Scientific Quality
60%
Moderate scientific quality: the phenotype-transfer design includes a meaningful transwell disconnection control and the study connects phenotype to multiple mechanistic assays and proteomics. However, from the provided excerpt, there is an evidence gap for causality (which protein(s) are sufficient/necessary in the transfer context), potential statistical robustness concerns for DEPs (multiple-testing correction not clearly shown for DEPs), and the carrier mechanism (exosomes/microvesicles/contacts) remains unresolved despite the transwell result.
Study Generality
50%
The study is grounded in specific breast cancer cell models (MCF-7 and a particular tamoxifen-resistant subline) and focuses on one endocrine axis. Generalization to diverse ER+ breast tumors, in vivo microenvironments, and other resistance trajectories is not demonstrated in the provided text.
Study Usefulness
60%
Useful for hypothesis generation: it provides a concrete mechanistic package (SNAIL1/p-NF-ΞΊB/N-cadherin/ERΞ± transcriptional suppression) plus candidate proteins from shared DEPs that can guide follow-up experiments.
Study Reproducibility
50%
Methods are detailed for proteomics acquisition/MaxQuant analysis and describe triplicate runs, but the excerpt does not provide full quantitative DEP statistics (e.g., complete lists, exact test definitions, and correction strategy for DEPs) and does not show raw proteomics outputs/data availability. Reproducibility is therefore only moderate.
Explanatory Depth
60%
The paper offers a coherent mechanistic narrative (contact-dependent transfer β EMT/NF-ΞΊB/SNAIL1 activation β ERΞ± transcriptional activity decrease β resistance) supported by multiple assays, but it stops short of establishing causal molecular drivers for the transferred phenotype and does not isolate the transfer payload.
{"note":"No in silico quantitative expected-value graph included because the prompt lacks the numeric marker intensities, tamoxifen viability/timecourse data, and full fold-change direction definitions needed for a truth-seeking quantitative cellular simulation."}
Generated scientific data; not direct experimental measurements.
Analysis Wizard
It will parse the paperβs reported protein fold-change lists into a structured table, then compute overlap and generate ranked enrichment summaries for candidate resistance/EMT proteins across the two resistant lines.
Get emailed when your analysis is done!
We'll email you the results when your analysis is finished.
Hypothesis Graveyard
βTransfer is purely diffusible paracrine factorsβ is weakened by the transwell (0.4 Β΅m) result showing prevented transfer, implying either direct contact or extremely localized factors near the membrane are required.
βERΞ± protein loss alone explains resistanceβ is disfavored by their report that ERΞ± protein level is not significantly changed while ERΞ± transcriptional activity decreases, pointing to functional repression of ERΞ± output rather than receptor abundance alone.